Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice

J Hepatol. 2013 Aug;59(2):285-91. doi: 10.1016/j.jhep.2013.03.021. Epub 2013 Mar 28.

Abstract

Background & aims: Conflicting results have been reported regarding the impact of hepatitis B virus X protein (HBx) expression on liver regeneration triggered by partial hepatectomy (PH). In the present report we investigated the mechanisms by which HBx protein alters hepatocyte proliferation after PH.

Methods: PH was performed on a transgenic mouse model in which HBx expression is under the control of viral regulatory elements and liver regeneration was monitored. LPS, IL-6 neutralizing antibody, and SB203580 were injected after PH to evaluate IL-6 participation during liver regeneration.

Results: Cell cycle progression of hepatocytes was delayed in HBx transgenic mice compared to WT animals. Moreover, HBx induced higher secretion of IL-6 soon after PH. Upregulation of IL-6 was associated with an elevation of STAT3 phosphorylation, SOCS3 transcript accumulation and a decrease in ERK1/2 phosphorylation in the livers of HBx transgenic mice. The involvement of IL-6 overexpression in cell cycle deregulation was confirmed by the inhibition of liver regeneration in control mice after the upregulation of IL-6 expression using LPS. In addition, IL-6 neutralization with antibodies was able to restore liver regeneration in HBx mice. Finally, the direct role of p38 in IL-6 secretion after PH was demonstrated using SB203580, a pharmacological inhibitor.

Conclusions: HBx is able to induce delayed hepatocyte proliferation after PH, and HBx-induced IL-6 overexpression is involved in delayed liver regeneration. By modulating IL-6 expression during liver proliferation induced by stimulation of the cellular microenvironment, HBx may participate in cell cycle deregulation and progression of liver disease.

Keywords: HBV; HBx; HCC; PH; hepatitis B virus; hepatitis B virus X protein; hepatocellular carcinoma; partial hepatectomy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing / administration & dosage
  • Cell Cycle
  • Cell Proliferation
  • Enhancer Elements, Genetic
  • Hepatectomy
  • Hepatitis B virus / genetics
  • Hepatitis B virus / pathogenicity
  • Hepatitis B virus / physiology
  • Hepatitis B, Chronic / immunology
  • Hepatitis B, Chronic / pathology
  • Hepatitis B, Chronic / virology
  • Hepatocytes / immunology
  • Hepatocytes / pathology
  • Hepatocytes / virology
  • Host-Pathogen Interactions
  • Humans
  • Imidazoles / administration & dosage
  • Interleukin-6 / antagonists & inhibitors
  • Interleukin-6 / physiology*
  • Liver Regeneration / genetics
  • Liver Regeneration / immunology
  • Liver Regeneration / physiology*
  • MAP Kinase Signaling System / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Models, Animal
  • Promoter Regions, Genetic
  • Pyridines / administration & dosage
  • Trans-Activators / genetics
  • Trans-Activators / physiology*
  • Viral Regulatory and Accessory Proteins

Substances

  • Antibodies, Neutralizing
  • Imidazoles
  • Interleukin-6
  • Pyridines
  • Trans-Activators
  • Viral Regulatory and Accessory Proteins
  • hepatitis B virus X protein
  • SB 203580